Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers.
about
Prognostic significance of micrometastatic bone marrow involvement.Human cancers express mutator phenotypes: origin, consequences and targeting.Characterization of disseminated tumor cells.Implications of occult metastatic cells for systemic cancer treatment in patients with breast or gastrointestinal cancer.Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells.Consensus recommendations for advancing breast cancer: risk identification and screening in ethnically diverse younger women.Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic featuresResistance of ovarian teratocarcinoma cell spheroids to complement-mediated lysis.Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis.Lung cancer: new surgical approaches.Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes.Detection of bone marrow-disseminated breast cancer cells using an RT-PCR assay of MUC5B mRNA.Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic targetComparative analyses of bone marrow micrometastases in breast and gastric cancer.Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis.Monoclonal antibody gene transfer. Implications for tumor-specific cell-mediated cytotoxicity.
P2860
Q33538449-3B2AE8F8-CE3F-4876-99CE-CC34F30B63A6Q33554201-BEF77AAF-E31F-410C-83AE-BE356FC45276Q34465174-D2F41B98-ADEE-45A5-9DDA-EE969E8941B9Q34465224-C0FA9AE4-D083-4E2D-8BE7-AE8C31ADFC87Q34475414-F921AC59-1C86-448B-92C8-B6F202E847EAQ34821135-8BD0EC04-DF99-4360-8890-CE3AC9DC30D1Q35755567-491819DB-73F6-4124-99B6-BCE9A26B097EQ35979137-C3384F49-3D25-40A3-B249-2919EFF74811Q36431698-05CE7016-C647-435C-A905-42017C5E2DA3Q36641784-5FD6D7EA-B3E1-4364-8833-AC20AB0FA1C4Q36835924-43C525E6-F845-4348-A6AE-C6FEEA3843E8Q38274384-6AC2147F-E083-4AA5-A71B-50172C5E0ECEQ40683906-75C24C1F-256C-4888-BD71-F8E742ED7523Q40865882-3C631EF2-0D62-4638-9529-37142E71C050Q43477202-01839027-6815-4361-948E-60F9278E2C15Q45835023-5BA99EF6-2E29-4C13-8A34-A9A04C193F00Q46149201-EB6D77A1-72BD-4DAD-8FC2-01313EA33779
P2860
Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers.
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers.
@ast
Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers.
@en
type
label
Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers.
@ast
Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers.
@en
prefLabel
Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers.
@ast
Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers.
@en
P1476
Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers.
@en
P2093
Johnson JP
Riethmüller G
P304
P356
10.1016/0952-7915(92)90041-C
P577
1992-10-01T00:00:00Z